Menu

Cytek Biosciences, Inc. CTKB

Full chart Compare
Set alert

Price alert · CTKB

All alert types
5.83 USD +0.43 (+7.96%)

At closeNov 6, 2026, 4:42 PM EST

5.83 0.00 0.00%

After hours · Nov 6, 4:42 PM ET

5.31 Day range 5.87
3.36 52-week range 6.30
YTD
+15.45%
1 year
+28.41%

Revenue & Expenses

Other Income → Expenses: $10.07MExpenses → Selling, General & Admin: $108.38MExpenses → Research & Development: $36.47MExpenses → Income Tax: $36.70MGross Profit → Expenses: $104.46MRevenue → Gross Profit: $104.46MRevenue → Cost of Revenue: $97.03MNet Loss → Expenses: $66.54MOther Income$10.07MGross Profit$104.46MNet Loss$66.54MCost of Revenue$97.03MExpenses$181.07MSelling, General & Admin$108.38MResearch & Development$36.47MIncome Tax$36.70MRevenue$201.49M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CTKB annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
201.49M200.45M193.01M164.04M127.95M
104.46M111.11M109.43M100.97M79.14M
-40.38M-20.52M-27.84M-1.80M9.16M
-66.54M-6.02M-12.15M2.58M3.00M
-0.52-0.05-0.090.02—
CTKB annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
90.85M98.75M167.63M299.50M364.62M
461.54M499.50M494.46M519.48M463.31M
119.80M103.76M101.39M93.93M57.92M
14.57M8.60M11.13M14.58M0
341.74M395.74M393.06M425.30M405.04M
CTKB annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-4.69M25.38M5.28M-12.23M4.63M
10.12M-82.97M-93.89M-55.91M-20.99M
-13.43M-15.82M-41.81M5.51M213.56M
-3.94M-3.44M-4.83M-9.87M-4.36M
-7.89M-68.89M-131.87M-65.12M198.50M